Drug Infusion Systems Market Growth Driven by Technological Integration Smart Infusion Devices and Evolving Hospital Infrastructure Globally

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug Infusion Systems Market- by Product (Large Volume Infusion Systems, Patient-Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems and Enteral Infusion Systems), Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics and Other Applications), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the global Drug Infusion Systems market is valued at US$ 11.64 billion in 2021, and it is expected to reach 24.04 Billion by the year 2031, with a CAGR of 8.90% during a forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1271

Infusion systems, typically designed as pumps, are employed to administer fluids, nutrients, or medications directly into a patient's circulatory system. While these systems are occasionally utilized for epidural and arterial infusions, their primary application lies in intravenous drug delivery, particularly for managing neurological and other chronic conditions. Drug infusion systems are widely adopted across multiple therapeutic areas, enabling the intravenous or non-oral administration of medications such as antibiotics, chemotherapeutic agents, insulin, and opioids.

The global drug infusion systems market is projected to witness substantial growth, driven by increasing demand for safe, accurate, and controlled drug delivery solutions, alongside the rising global burden of chronic diseases. These systems are engineered to provide precise dosing capabilities, often integrated with technologies that assist healthcare professionals by automatically calculating and displaying appropriate dosages. The enhanced safety, accuracy, and efficiency offered by infusion systems are expected to further support their adoption within clinical settings.

Additionally, the expanding use of infusion systems in chronic pain management, particularly in the treatment of conditions such as diabetes, is anticipated to bolster market growth. The increasing application of infusion systems for hemodynamic regulation and control is also expected to play a significant role in driving market expansion throughout the forecast period.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

North America is expected to remain the dominant region in the Drug Infusion Systems market over the forecast period, primarily due to the high prevalence of chronic diseases in countries such as the United States and Canada. The increasing volume of medical procedures conducted in hospitals across the region is also anticipated to contribute significantly to market growth.

Conversely, the Asia Pacific region is projected to witness substantial market expansion in the coming years. This growth is largely driven by the rising incidence of chronic conditions such as diabetes and cancer across several countries in the region. Furthermore, growing government investments aimed at enhancing healthcare infrastructure and facilitating the adoption of advanced medical technologies are expected to further accelerate the development of the Drug Infusion Systems market in Asia Pacific.

Major market players operating in the Drug Infusion Systems market include
Acromed AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc., Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Debiotech S.A., Halyard Health, Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic, ICU Medical Inc., MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation and Zyno Medical, LLC among others.

Recent collaborations and agreements in the market:
• In August 2021, Smiths Medical and Ivenix announced a collaboration on best-in-class infusion management technology to improve the infusion administration process.
• In July 2021, Innovative Health Sciences announced the CE mark for a syringe infusion system.
• In May 2020,International Baxter Inc. The Evo IQ Infusion System has acquired CE certification and regulatory approval from Australia's Therapeutic Goods Administration, according to Baxter International Inc., a global pioneer in advanced drug delivery technology (TGA). With the release of the Evo IQ Infusion System, there is now a wider range of infusion therapy options for different types of patients.
• In January 2020, Medtronic (Ireland) released Efficio, a cloud-based data management software designed to work with the SynchroMed II intrathecal medication delivery system. This allows clinicians to manage their targeted medication delivery pump procedures more efficiently while treating patients with chronic pain, cancer, and severe spasticity.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1271

Market Segments
Global Drug Infusion Systems Market, by Product Type, 2022-2030 (Value US$ Mn)
• Large Volume Infusion Systems
• Patient-Controlled Analgesia
• Elastomeric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Systems
• Implantable Infusion Systems
• Ambulatory Infusion Systems
• Enteral Infusion Systems
Global Drug Infusion Systems Market, by Application, 2022-2030 (Value US$ Mn)
• Oncology/Chemotherapy
• Diabetes
• Analgesia
• Nutrition
• Haematology
• Paediatrics
• Other Applications
Global Drug Infusion Systems Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Drug Infusion Systems market
 To receive an industry overview and future trends of the Drug Infusion Systems market
 To analyze the Drug Infusion Systems market drivers and challenges
 To get information on the Drug Infusion Systems market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Drug Infusion Systems market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-drug-infusion-systems-market/1271

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.